Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease: Actin, desmin, myosin, and tropomyosin

American Journal of Pathology

Volumn 142, Issue 1, 1993, Pages 221-230

  Shoeman, Robert L ^a   Sachse, Comelia ^a   Höner, Bernd ^a   Mothes, Elfriede ^a   Kaufmann, Manfred ^b   Traub, Peter ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; F ACTIN; G ACTIN; MYOSIN HEAVY CHAIN; PROTEINASE; TROPOMYOSIN; VIRUS ENZYME;

ARTICLE; CELL ULTRASTRUCTURE; CYTOARCHITECTURE; CYTOSKELETON; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACTINS; ANIMAL; DESMIN; HELA CELLS; HIV PROTEASE; HUMAN; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; MYOSINS; SARCOMERES; SUPPORT, NON-U.S. GOV'T; TROPOMYOSIN; VIRAL PROTEINS;

EID: 0027529843     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Varmus H: Retroviruses. Science 1988, 240:1427-1435
2. Kräusslich H-G, Wimmer E: Viral proteinases. Annu Rev Biochem 1988, 57:701-754
3. Kay J, Dunn BM: Viral proteinases: Weakness in strength. Biochim Biophys Acta 1990, 1048:1-18
4. Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RAF, Scolnick EM, Sigal IG: Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 1988, 85:4686-4690
5. LeGrice S, Mills J, Mous J: Active site mutagenesis of the AIDS virus protease and its alleviation by transcomplementation. EMBO J 1988, 7:2547-2553
6. Peng C, Ho BK, Chang TW, Chang NT: Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 1989, 63:2550-2556
7. Göttlinger HG, Sodroski JG, Haseltine WA: Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989, 86:5781-5785
8. Seelmeier S, Schmidt H, Turk V, von der Helm K: Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc Natl Acad Sci USA 1988, 85:6612-6616
9. von der Helm K, Gürtler L, Eberle J, Deinhardt F: Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett 1989, 247:349-352
10. Ashorn P, McQuade TJ, Thaisrivong S, Tomasselli AG, Tarpley WG, Moss B: An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc Natl Acad Sci USA 1990, 87:7472-7476
11. Grinde B, Hungnes O, Tjotta E: Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication. Arch Virol 1990, 114:167-173
12. Kaplan AH, Swanstrom R: Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sci USA 1991, 88:4528-4532
13. Shoeman RL, Höner B, Stoller TJ, Kesselmeier C, Miedel MC, Traub P, Graves MC: Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin and glial fibrillary acidic protein. Proc Natl Acad Sci USA 1990, 87:6336-6340
14. Shoeman RL, Mothes E, Kesselmeier C, Traub P: Intermediate filament assembly and stability in vitro: Effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease. Cell Biol Int Rep 1990, 14:583-594
15. Shoeman RL, Kesselmeier C, Mothes E, Höner B, Traub P: Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett 1991, 278:199-203
16. Wallin M, Deinum J, Goobar L, Danielson UH: Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases. J Gen Virol 1990, 71:1985-1991
17. Riviere Y, Blank V, Kourilsky P, Israel A: Processing of the precursor of NF-kappa-B by the HIV-1 protease during acute infection. Nature 1991, 350:625-626
18. Tomasselli AG, Hui JO, Adams L, Chosay J, Lowery D, Greenberg B. Yem A, Deibel MR, Zürcher-Neely H, Heinrikson RL: Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 10 as substrates of the protease from human immunodeficiency virus. J Biol Chem 1991, 266:14548-14553
19. Oswald M, von der Helm K: Fibronectin is a non-viral substrate for the HIV proteinase. FEBS Lett 1991, 292:298-300
20. Höner B, Shoeman RL, Traub P: Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J Cell Sci 1991, 100:799-807
21. Adams LD, Tomasselli AG, Robbins P, Moss B, Heinrikson RL: HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. Aids Res Hum Retroviruses 1992, 8:291-294
22. Willingale-Theune J, Schweiger M, Hirsch-Kauffmann M, Meek AE, Paulin-Levasseur M, Traub P: Ultrastructure of Fanconi anemia fibroblasts. J Cell Sci 1989. 93:651-665
23. Weir JB, Fredericksen DW: Section III. Methods for study of the motility apparatus in nonmuscle cells. 34. Preparation of cytoplasmic actin. Meth Enzymol 1982. 85:371-373
24. Koffer A, Dickens MJ: Isolation and characterization of actin from cultured BHK cells. J Muscle Res Cell Motil 1987, 8:397-406
25. Yerna M-J, Aksoy MO, Hartshorne DJ, Goldman RD: BHK21 myosin: Isolation, biochemical characterization and intracellular localization. J Cell Sci 1978, 31:411-429
26. Knight PJ, Trinick JA: Section I. Methods for striated muscle chemistry. 2. Preparation of myofibrils. Meth Enzymol 1982, 85:9-12
27. Shoeman RL, Höner B, Mothes E, Traub P: Cleavage of cytoskeletal proteins by the human immunodeficiency virus type 1 protease (abstr). J Cell Biol 1990, 111:305a
28. Holmes KC, Popp D, Gebhard W. Kabsch W: Atomic model of the actin filament. Nature 1990, 347:44-49
29. Carlier M-F: Actin: Protein structure and filament dynamics. J Biol Chem 1991, 266:1-4
30. Shoeman RL, Höner B, Mothes E, Traub P: Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis. Med Hypotheses 1992, 37:137-150
31. Gonzales MF, Olney R, Yuen PS, Greco CM, McQuinn BA, Miller RG. de Armond SJ: Subacute structural myopathy associated with human immunodeficiency viral infection. Arch Neurol 1988, 45:585-587
32. Simpson DM, Bender AN, Farraye J, Mendelson SG, Wolfe DE: Human immunodeficiency virus wasting syndrome may represent a treatable myopathy. Neurology 1990, 40:535-537
33. Sharpe AH, Hunter JJ, Chassler P, Jaenisch R: Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 1990, 346:181-183
34. Wong PKY: Moloney murine leukemia virus temperature-sensitive mutants: A model for retrovirus-induced neurologic disorders. Curr Topics Microbiol Immunol 1990, 160:29-60
35. Tomasselli AG, Howe WJ, Sawyer TK, Wlodawer A, Heinrikson RL: The complexities of AIDS: An assessment of the HIV protease as a therapeutic target. Chimica Oggi 1991, 9:6-27
36. Mothes E, Shoeman RL, Schröder RR, Traub P: Palymerizing properties of pepstatin A. J Struct Biol 1990, 105:80-91